Eyal Shalmon is member of Kibbutz Maabarot, a majority shareholder of Maabarot Products Ltd. Mr Shalmon is chairman of both Maabarot and Lordan Coils Boards.
Previously, over the last 16 years, Eyal Shalmon served as CFO and M&A Director with several listed companies such as Maabarot and EMT and has a strong background in strategy, finance and business development. Mr Shalmon holds an MBA from Heriot-Watt University.
Eric MARTY is Investment Director at Demeter-Emertec and lead investor of the company
Eric Marty represents Demeter-Emertec in Algaia's Board. He is graduated from the prestigious French chemical engineering school Chimie-Paris Tech.
Between 1990 and 2004, he held several positions within large chemical groups such as Rhodia (now Solvay) or refining industry player like IFPE in Europe and Latin America.
Since 2004, Mr. Marty is a partner and member of the managing board of Emertec Gestion, now Demeter-Emertec, the major European private equity player investing in early stage innovative technological companies and being today the largest investor within Algaia.
M. Marty currently serves on the board of directors of innovative biotech and nutrition companies like Algaia, Alderys (Biotech) and Olygose (soluble fiber from vegetables) as well as on the boards of several French companies in the field of Energy and environmental technologies.
Emertec Gestion was one of the early investor in Fermentalg (micro-algae based products for Food, feed and other applications) that was successfully put on the stock market in 2014 and Ynsect (developing value added components from insects).
Celia HART is Investment Director in Life Sciences at CEA Investissement and second largest investor
Celia Hart is CEA Investissement’s representative on the board of Algaia. She has more than 20 years’ experience in the chemical and biotechnology sector.
She did her PhD in protein engineering and metabolic engineering at Oxford University (UK) in a laboratory that worked closely with Industry (GSK, DSM).
Celia then worked in the UK Biotechnology industry at Cambridge Antibody Technology (now Medimmune) where she was the Head of Lead Optimisation and led the R&D development of several therapeutic antibodies.
Since then she has been assessing new business opportunities built on strong science at leading institutions (ESRF, CEA). She joined CEA Investissement (France) in 2005 and is now Investment Director and in charge of the life science sector. She serves (or has served) on the Board of several companies including Algaia, Fermentalg (micro-algae, 2014 IPO), Cytoo, ImmunId, Bioaxial and Theranexus (Biotech pharma).
Celia holds a degree in Chemistry from the University of Geneva (Switzerland), a PhD from the University of Oxford (UK) and an MBA from Grenoble Ecole de Management (France).
Mr Danny Taragan is Maabarot Products Ltd's CEO since January 2016 and is an experienced businessman who served as CEO with several international companies.
Previously CEO of Bagir International, Mr Taragan served 17 years as the CEO of Tana Waters where he grew the business exponentially and was recognized as one of the top 50 most influential personality in the water industry worldwide. Mr Taragan holds an MBA from the Hebrew University in Jerusalem and lives in Kibbutz Netiv in Israel.
LAGARDE is Specialist in Food Ingredients Industry and acts as
independent board member
Gilles Lagarde has more than 30 years of experience in the fields of Fermentation and Extraction; he is one of the most recognized senior leaders of the specialty food ingredients industry.
During his career, he was VP and General Manager of Sanofi Bio-Industries (Cultures and Enzymes Division) and SBI/SKW (Food Ingredients and Additives Division).
In 1999, he finally joined NEOVA (formerly known as Inovatech Bio-Products, a specialty group dedicated to the development of ingredients for the healthcare, food and feed industries) as Executive VP and Shareholder. He was also the founder and the first President of EFFCA (European Food & Feed Cultures Association).
Fabrice BOHIN, is ALGAIA’s President of the board
Fabrice has over 20 years’ experience in the Specialty Food Ingredient sector, servicing the FMCG market through a B2B approach. He started his career at Rhodia (now Solvay) in 1994 where he worked mostly for its Food ingredient division in various roles such as Application lab manager, Business Development, Marketing, Strategy, Business Development Director (M&A), Corporate Account Leader, Vice General Manager and International Business Director for product lines ranging from lactic Bacteria’s, Biogums, Seaweed Extracts, Plant Extracts and Food systems.
In 2004, he joined Cargill as Business Development Director to help the company entering into the specialty food ingredient sector through external and internal growth. After two acquisitions in a row, Cargill became one of the top four leaders in the Texturizing Solution arena and Fabrice was offered the position of Global Business Director of Cargill newly integrated Hydrocolloid portfolio composed of Pectin (fruit extracts), Carrageenans & Alginates (seaweed extracts), LBG (plant extracts) and Biogums (functional polysaccharides produced through fermentation). Starting 2012, he was also in charge of Cargill Texturizing Solutions functional food system business for Europe.
In Cargill, Fabrice was managing a business of over 300m$ revenue where both top and bottom line improved double to triple digits over the period. He joined ALGAIA in June 2014 as the new CEO of the company.
Patrick MEWTON is the founder of CLOTILDE LIMITED, an Independent Corporate Finance Advisory House dedicated to the Global Agribusiness and Value-Added Ingredients Sectors, and acts as independent board member.
Patrick Mewton has 20 years of Investment Banking experience during which time he has predominantly focused on Mergers & Acquisitions across the global Business-to-Business sector where he has worked on in excess of 100 transactions across every continent.
During his career Patrick was a shareholder at McQueen Limited, the leading European Consumer –focused M&A house, and became a Managing Director at Houlihan Lokey following its acquisition of McQueen Limited in 2015. Previously to McQueen, Patrick was the Global Head of Commodities & Ingredients M&A at Rabobank/Rothschild and he has also worked at ABN AMRO and Deutsche Bank. In 2016 Patrick founded Clotilde Limited.